Manipulation of the Innate Immune Response by Varicella Zoster Virus. 2020

Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
Infectious Diseases and Immunology, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.

Varicella zoster virus (VZV) is the causative agent of chickenpox (varicella) and shingles (herpes zoster). VZV and other members of the herpesvirus family are distinguished by their ability to establish a latent infection, with the potential to reactivate and spread virus to other susceptible individuals. This lifelong relationship continually subjects VZV to the host immune system and as such VZV has evolved a plethora of strategies to evade and manipulate the immune response. This review will focus on our current understanding of the innate anti-viral control mechanisms faced by VZV. We will also discuss the diverse array of strategies employed by VZV to regulate these innate immune responses and highlight new knowledge on the interactions between VZV and human innate immune cells.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D012157 Mononuclear Phagocyte System Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.) Reticuloendothelial System,Phagocyte System, Mononuclear,System, Mononuclear Phagocyte,System, Reticuloendothelial
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085343 Latent Infection Delayed infection of the host by a dormant or inactive pathogen. Infection Reactivation,Reactivated Infection,Reactivation Infection,Infection Reactivations,Infection, Latent,Infection, Reactivated,Infection, Reactivation,Latent Infections,Reactivation Infections,Reactivation, Infection
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus
D016366 Open Reading Frames A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon (CODON, TERMINATOR). ORFs,Protein Coding Region,Small Open Reading Frame,Small Open Reading Frames,sORF,Unassigned Reading Frame,Unassigned Reading Frames,Unidentified Reading Frame,Coding Region, Protein,Frame, Unidentified Reading,ORF,Open Reading Frame,Protein Coding Regions,Reading Frame, Open,Reading Frame, Unassigned,Reading Frame, Unidentified,Region, Protein Coding,Unidentified Reading Frames

Related Publications

Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
February 2011, PloS one,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
May 2011, Vaccine,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
April 1999, Immunological reviews,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
January 1985, Postgraduate medical journal,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
January 2010, Current topics in microbiology and immunology,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
September 1996, Infectious disease clinics of North America,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
May 1995, The Journal of infectious diseases,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
November 2011, Journal of virology,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
June 1985, Biken journal,
Chelsea Gerada, and Tessa M Campbell, and Jarrod J Kennedy, and Brian P McSharry, and Megan Steain, and Barry Slobedman, and Allison Abendroth
March 2017, Virus research,
Copied contents to your clipboard!